Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

16

Revenue 2017

Tecfidera

The Top Pharma List's top 50 pharmaceutical products by global sales ranking is compiled from GlobalData's pharmaceutical revenue figures. Tecfidera was produced by Biogen Idec.

Biogen cuts $217m deal for Karyopharm neurology drug

Biogen cuts $217m deal for Karyopharm neurology drug Biogen reported 2017 revenues of $12.3bn, up 15% on the prior year, thanks to gains for its multiple sclerosis drugs, particularly Tecfidera (dimethyl fumarate) and rising royalties from Ocrevus (ocrelizumab) -

Sanofi licences Principia MS drug in $805m deal

Sanofi licences Principia MS drug in $805m deal With a 27% growth it is still one of Sanofi’s most important products, but is still lagging behind Biogen’s market-leading Tecfidera (dimethyl fumarate) which brought in almost

Merck gets CHMP backing for long-delayed oral MS drug

Merck gets CHMP backing for long-delayed oral MS drug competitive landscape" - with oral therapies such as Novartis' Gilenya (fingolimod) and Biogen's Tecfidera (dimethyl glutamate) reaching or near the market. ... Mavenclad will launch into a market where Tecfidera is currently dominating with sales of

Biogen wins European spinal muscular atrophy first

Biogen wins European spinal muscular atrophy first The biotech needs Spinraza to be a success, as it faces competitive pressure on flagship multiple sclerosis therapy Tecfidera (dimethyl fumarate) and casts around to bulk up what some suggest is

Deal Watch January 2017

Deal Watch January 2017 In a similar vein, Forward Pharma and Biogen also reached a settlement agreement over the Tecfidera patent dispute by closing an irrevocable licence valued at $1.25bn. ... Biogen. Patent settlement. Tecfidera (dimethyl fumarate). 1, 250. Merrimack

[ Previous 5 results ] 1 2 3 4 5 6 7 8 9 10 [ Next 5 results ]

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Attigo (part of the Mednet Group)

Inclusion drives innovation. Attigo, a social enterprise, helps pharma and the socially conscious business shape the future by engaging with...

Latest intelligence

Multichannel engagement and the need for greater understanding of European markets
By Laurence Olding and Georgina James...
A snapshot of… Exscientia
...
Patients are ready for virtual clinical trials, are you?
Traditional clinical trial designs simply can’t withstand the impact of COVID-19. While before the pandemic, some in clinical research were beginning to adopt virtual components, the move towards designing hybrid...

Infographics